Proteomic identification of membrane proteins regulating antimicrobial peptide resistance in Vibrio parahaemolyticus.
OBJECTIVE
To identify proteins regulating antimicrobial peptide (AMP) resistance in Vibrio parahaemolyticus using membrane subproteome analysis.


RESULTS
Three synthetic AMPs (Q4, Q6 and H1) and a natural one from fish (pleurocidin) were used for selection of AMP-resistant strains. Differential expression patterns of the outer and inner membrane proteins (OMPs and IMPs) among wild-type and the resistant strains were obtained using two-dimensional gel electrophoresis. Two OMPs (TolC and flagellin) and five IMPs [transcription termination factor (NusA), long-chain fatty acid transport protein (FadL), elongation factor Tu (EF-Tu), ATP synthase F1, alpha subunit (F1-ATPa) and dihydrolipoamide dehydrogenase (DLD)] were identified using LC-ESI-Q-TOF MS/MS and Mascot program. Real-time quantitative polymerase chain reaction was also performed to determine the mRNA expression level of the target genes. All seven membrane proteins except FadL were upregulated in the AMP-resistant clones, both in the translational and transcriptional levels.


CONCLUSIONS
Our results suggested that V. parahaemolyticus may obtain their resistance against AMPs through upregulation of the multidrug efflux transporter, effective repair of damaged membranes and prevention of cellular penetration of AMPs.


CONCLUSIONS
To the best of our knowledge, this is the first report describing bacterial AMP resistance mechanism using proteomic methodologies. Elucidating the mechanism could help in the development of more sustainable antimicrobial agents.
Graduate Institute of Biotechnology, College of Bioresources, National Ilan University, Ilan, Taiwan.
C-J
CJ
Shen
T-Y
TY
Kuo
C-C
CC
Lin
L-P
LP
Chow
W-J
WJ
Chen
D000890:Anti-Infective Agents / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial / Q000235:genetics; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D010455:Peptides / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology; D040901:Proteomics; D014736:Vibrio parahaemolyticus / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism*
D000890:Anti-Infective Agents; D008565:Membrane Proteins; D010455:Peptides